Dr. Adriana Saltijeral of the University Hospital del Tajo (Aranjuez, Madrid) interviews Dr. Leopoldo Pérez de Isla, of the San Carlos Clinical Hospital of Madrid and member of the Scientific Committee of the Family Hypercholesterolemia Foundation, to talk about the importance of knowing the size of LDL cholesterol particles to stratify cardiovascular risk.
Dr. Pérez de Isla explains which individuals can benefit most from this analysis, which studies demonstrate their benefit in risk staging and how a technique that allows the characterization of lipoproteins based on 2D diffusion NMR spectroscopy, to estimate the risk and intensify the treatment in those patients who need it.
The video with the interview can be seen on this link (this video is in Spanish)
